Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M71.7Revenue $M0.2Net Margin (%)-10,352.6Z-Score-10.5
Enterprise Value $M47.9EPS $-0.7Operating Margin %-11,437.4F-Score4
P/E(ttm))0Cash Flow Per Share $-0.1Pre-tax Margin (%)-10,352.6Higher ROA y-yN
Price/Book4.010-y EBITDA Growth Rate %0Quick Ratio4.8Cash flow > EarningsY
Price/Sales2145-y EBITDA Growth Rate %0Current Ratio5.2Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-86.8Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-145.3Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M65.9ROI % (ttm)-121.7Gross Margin Increase y-yN

Gurus Latest Trades with CVM

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

CVM is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


CVM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KERSTEN GEERT RCEO 2013-12-30Buy300,000$0.653.33 view
KERSTEN GEERT RChief Executive 2013-10-09Buy8,400$0.7916.46 view
YOUNG PETER RDirector 2013-06-19Buy25,000$0.24283.33 view
KERSTEN GEERT RChief Executive 2013-06-14Buy145,120$0.24283.33 view
KERSTEN GEERT RCEO 2013-05-20Buy40,000$0.25268 view
KERSTEN GEERT RCEO 2013-05-02Buy118,700$0.27240.74 view
PRICHEP PATRICIA BSenior Vice President 2013-03-27Buy25,000$0.22318.18 view
YOUNG PETER RDirector 2013-03-27Buy25,000$0.23300 view
KERSTEN GEERT RCEO 2013-03-26Buy348,125$0.21338.1 view
DE CLARA MAXIMILIANPresident 2011-03-07Sell100,000$0.6150.82 view

Press Releases about CVM :

    Quarterly/Annual Reports about CVM:

    News about CVM:

    Articles On GuruFocus.com
    CELSCISci Corp Reports Operating Results (10-Q) Feb 09 2011 
    CELSCISci Corp Reports Operating Results (10-Q) Aug 16 2010 
    CELSCISci Corp Reports Operating Results (10-Q) May 17 2010 
    CELSCISci Corp Reports Operating Results (10-Q) Feb 12 2010 
    CELSCISci Corp Reports Operating Results (10-Q/A) Feb 01 2010 
    CELSCISci Corp Reports Operating Results (10-Q/A) Feb 01 2010 
    CELSCISci Corp Reports Operating Results (10-Q/A) Jan 29 2010 
    CELSCISci Corp Reports Operating Results (10-K) Jan 13 2010 
    CELSCISci Corp Reports Operating Results (10-Q) Aug 14 2009 
    CELSCISci Corp Reports Operating Results (10-Q) Aug 14 2009 

    More From Other Websites
    University of Minnesota Masonic Cancer Center Joins CEL-SCI’s Phase III Head & Neck Cancer Trial Sep 10 2014
    CEL-SCI Enrolls 20 Patients in August in Its Phase III Immunotherapy Head and Neck Cancer Trial Sep 03 2014
    CEL SCI CORP Financials Aug 19 2014
    CEL-SCI Expands its Global Phase III Immunotherapy Head and Neck Cancer Trial into Centre... Aug 19 2014
    CEL SCI CORP Files SEC form 10-Q, Quarterly Report Aug 08 2014
    CEL-SCI Corporation Reports Third Quarter Fiscal 2014 Financial Results Aug 08 2014
    CEL SCI CORP Files SEC form 8-K, Change in Directors or Principal Officers Aug 07 2014
    Cel-Sci's Enrollment Math Doesn't Add up Aug 01 2014
    CEL-SCI Achieves Milestone in July with Total of 232 Patients Enrolled to Date in Its Phase III Head... Aug 01 2014
    France Becomes 17th Country to Clear CEL-SCI for Patient Enrollment in Its Global Phase III Head and... Jul 30 2014
    CEL SCI CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jul 23 2014
    CEL-SCI Has Been Cleared to Begin Patient Enrollment Jul 23 2014
    CEL-SCI Receives Regulatory Clearance to Expand Phase III Head and Neck Cancer Trial into Turkey Jul 22 2014
    CEL-SCI Expands Its Phase III Head and Neck Cancer Trial into Sri Lanka Jul 17 2014
    CEL-SCI Expands Its Phase III Head and Neck Cancer Trial into Sri Lanka Jul 17 2014
    CEL-SCI Receives $225,000 NIH Research Grant to Develop Rheumatoid Arthritis Treatment Jul 15 2014
    CEL-SCI Presents Rheumatoid Arthritis Data at the 12th Vaccines Research & Development: All Things... Jul 11 2014
    CEL-SCI Receives Regulatory Clearance to Expand CEL-SCI’S Phase III Head and Neck Cancer Trial... Jul 08 2014
    CEL-SCI Reports Continued Increase in Sequential Quarterly Patient Enrollment in Its Phase III Head... Jun 03 2014
    CEL-SCI receives approval to expand Phase III trial to U.K. Jun 02 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK